Nicole carnt, jeremy hoffman, seema verma, cherry radford, darwin c.Minassian and john k.G.Dart: acanthamoeba keratitis: confirmation of a current (b)(6) outbreak and a prospective case control study identifying contributing risk factors.(b)(4).
|
On 23 march 2018, an email was received from an eye care professional (ecp).The ecp is the author of a prospective study, conducted in the (b)(6), that has been submitted for publication in 2018.The email contained an attached summary data spreadsheet containing the medical information for subjects involved in the prospective acanthamoeba keratitis study.The information received from the ecp included only those study subjects who reported wearing acuvue brand products at the time of the adverse event.All the study subjects were initially examined and diagnosed with acanthamoeba keratitis during 2011-2014.The patient (pt), study id (b)(6), presented to the hospital on (b)(6) 2013 with severe glare, severe pain, slight redness, and swelling os.The pt was diagnosed with acanthamoeba keratitis os.The pt reported wearing an acuvue trueye brand contact lens (it is unknown if the pt was wearing nara a or nara b brand).Pt reports participating in water sports with no goggles and showered in lenses.The pt was admitted for 3 days for intensive treatment.Treatment also included antiemoebics for 15 months and doxyclyclene.Va: 6/9 (20/30).Pt did not return for follow-up.No additional information is expected to be received.The lot number of the suspect product is unknown.Suspect product is not available for return for evaluation.If additional information is received it will be reported within 30 days of receipt.Serious reportable event trends are reviewed quarterly in franchise management review meetings.
|